Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration
The benefit of intravitreal anti-VEGF therapy in treating wet age-related macular degeneration (AMD) is well established. Identification of VEGFR-2 inhibitors with optimal ADME properties for an ocular indication provides opportunities for dosing routes beyond intravitreal injection. We employed a h...
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Rannpháirtithe: | |
Formáid: | Journal Article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2016
|
Ábhair: | |
Rochtain ar líne: | https://hdl.handle.net/10356/81558 http://hdl.handle.net/10220/39573 |